Revised SPC: Harvoni (ledipasvir and sofosbuvir) film-coated tablets

A number of sections of the SPC have been revised to take account of an extension to the indication, to include use in paediatric patients aged 3 to <12 years. A new strength of film-coated tablets (45mg/200mg; combined SPC) and oral granules are also now available.


electronic Medicines compendium